Bufexamac in die Standardserie? Ergebnisse einer Studie des Informationsverbundes Dermatologischer Kliniken (IVDK) = Bufexamac in the standard patch-test screening tray / Results of a study by the Information Network of Departments of Dermatology (IVDK)SZOLAR-PLATZER, C; ABERER, W; KRÄNKE, B et al.Dermatosen in Beruf und Umwelt. 1998, Vol 46, Num 2, pp 81-83, issn 0343-2432Article

À propos d'un cas d'érythème polymorphe. Effets indésirables du bufexamac = Erythema multiforme case report and adverse effects of bufexamacISKANDAR, M. J; BRAVARD, P; DE FOURMESTRAUX, A et al.Les Nouvelles dermatologiques. 2003, Vol 22, Num 3, pp 144-146, issn 0752-5370, 3 p.Conference Paper

TOSSICITA CRONICA DEL BUFEXAMAC NEL RATTO E NELLA SCIMMIA = TOXICITE CHRONIQUE DU BUFEXAMAC CHEZ LE RAT ET LE SINGELAMBELIN G; ROBA J; RONCUCCI R et al.1974; BOLL. CHIM. FARM.; ITAL.; DA. 1974; VOL. 113; NO 8; PP. 437-454; ABS. ANGL.; BIBL. 7 REF.Article

ETUDE CLINIQUE DE L'ACTIVITE THERAPEUTIQUE DU BRIFEXAMAC CREME ET ONGUENT EN MEDECINE PHYSIQUE APRES TROIS ANS D'UTILISATIONPAQUE GR.1972; J. BELGE RHUMATOL. MED. PHYS.; BELG.; DA. 1972; VOL. 27; NO 2; PP. 90-95; ABS. ANGL.; BIBL. 1P.Serial Issue

PARFENAC CREME: UN ANTI-INFLAMMATOIRE NON STEROIDIEN. BROLITENE: MYORELAXANT SANS EFFET SUR LA VIGILANCE1975; CONCOURS MED.; FR.; DA. 1975; VOL. 97; NO 11; PP. 1883-1886 (3P.); BIBL. 14 REF.Article

Epidemiological significance of bufexamac as a frequent and relevant contact sensitizerKRÄNKE, B; SZOLAR-PLATZER, C; KOMERICKI, P et al.Contact dermatitis. 1997, Vol 36, Num 4, pp 212-215, issn 0105-1873Article

MUTAGENICITY STUDIES ON BUFEXAMACFABRY L; LEONARD A; DECAT G et al.1982; MUTAT. RES.; ISSN 0027-5107; NLD; DA. 1982; VOL. 103; NO 2; PP. 107-109; BIBL. 13 REF.Article

TRATTAMENTO DELLE DERMATORI CON VIAFEN UNGUENTO = TRAITEMENT DE DERMATOSES AVEC VIAFEN (ONGUENT)VISONA G; OBERHAUSER V.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979 PUBL. 1980; VOL. 114; NO 12; PP. 703-710; ABS. ENG; BIBL. 18 REF.Article

IL VIAFEN, NUOVO PREPARATO ANTINFIAMMATORIO NON STEROIDEO, NELLA PRATICA DERMATOLOGICA = LE "VIAFEN", NOUVELLE PREPARATION ANTIINFLAMMATOIRE NON STEROIDE, DANS LA PRATIQUE DERMATOLOGIQUESABBIONI L; OBERHAUSER V.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; NO 10; PP. 537-545; ABS. ENG; BIBL. 14 REF.Article

IDENTIFICAZIONE DI ALCUNI AGENTI ANTI-INFIAMMATORI NON STEROIDEI. = IDENTIFICATION DE QUELQUES AGENTS ANTI-INFLAMMATOIRES NON STEROIDELOTTI B.1975; BOLL. CHIM. FARM.; ITAL.; DA. 1975; VOL. 114; NO 6; PP. 351-354; ABS. ANGL.; BIBL. 6 REF.Article

CLINICAL EVALUATION OF A NEW, SYNTHETIC, NON-STEROID, TOPICAL AGENT-BUFEXAMACBILIMORIA FE; SHAH BH.1974; INDIAN J. DERMATOL. VENEREOL.; INDIA; DA. 1974; VOL. 40; NO 3; PP. 117-119Article

Bufexamac and diclofenac : frequency of contact sensitization and absence of cross-reactionsBARBAUD, A; TRECHOT, P; AUBLET-CUVELIER, A et al.Contact dermatitis. 1998, Vol 39, Num 5, pp 272-273, issn 0105-1873Article

Patient mit Dermatitis atopica sowie Kontaktallergien auf Clobetasol-17-propionat und Bufexamac = Patient with atopic dermatitis and contact eczema due to clobetasol-17-propionate and bufexamacFUHRMANN, H.-J; SORHAGE, B.H + G. Zeitschrift für Hautkrankheiten. 1998, Vol 73, Num 1, pp 39-41, issn 0301-0481Article

BUFEXAMAC: A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN INFLAMMATORY DERMATOSES. = BUFEXAMAC: REVUE DE SES PROPRIETES PHARMACOLOGIQUES ET DE SON EFFICACITE THERAPEUTIQUE DANS LES DERMATOSES INFLAMMATOIRESBROGDEN RN; PINDER RM; SAWYER PR et al.1975; DRUGS; SWITZ.; DA. 1975; VOL. 10; NO 5-6; PP. 351-356; BIBL. 19 REF.Article

Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girlBELHADJALI, H; GHANNOUCHI, N; NJIM, L et al.Contact dermatitis. 2008, Vol 58, Num 4, pp 247-248, issn 0105-1873, 2 p.Article

Kontaktallergie durch Bufexamac unter dem Bild einer chronischen Pigmentpurpura = Bufexamac-induced pigmented purpuric eruptionWALTERMANN, K; MARSCH, W. Ch; KREFT, B et al.Der Hautarzt. 2009, Vol 60, Num 5, pp 424-427, issn 0017-8470, 4 p.Article

Allergic contact dermatitis to topical preparations of bufexamacYAN PAN; NIXON, Rosemary.Australasian journal of dermatology. 2012, Vol 53, Num 3, pp 207-210, issn 0004-8380, 4 p.Article

L'allergie au bufexamac : Naissance d'un réseau de vigilance en dermato-allergologie = Bufexamac allergy. Creation of a dermato-allergology surveillance networkVIGAN, M.Revue française d'allergologie et d'immunologie clinique. 1999, Vol 39, Num 4, pp 299-300, issn 0335-7457Conference Paper

RILIEVI CLINICI E CONSIDERAZIONI SU UN PREPARATO ANTIINFLAMMATORIO, NON CORTISONICO, PER USO DERMATOLOGICO TOPICO. = DONNEES CLINIQUES ET CONSIDERATIONS SUR UNE PREPARATION ANTIINFLAMMATOIRE NON CORTISONIQUE POUR USAGE LOCAL EN DERMATOLOGIEREBOLDI A; DAL POZZO V.1976; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITAL.; DA. 1976; VOL. 111; NO 10; PP. 607-613; ABS. ANGL.Article

CONTACT DERMATITIS TO BUFEXAMACREIFFERS J.1982; DERMATOLOGICA; ISSN 0011-9075; CHE; DA. 1982; VOL. 164; NO 5; PP. 354-356; BIBL. 3 REF.Article

Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of actionTROMMER, Hagen; PLÄTZER, Manuela; RAITH, Klaus et al.Journal of pharmacy and pharmacology. 2003, Vol 55, Num 10, pp 1379-1388, issn 0022-3573, 10 p.Article

Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamacKURUMAJI, Y.Dermatology (Basel). 1998, Vol 197, Num 2, pp 183-186, issn 1018-8665Conference Paper

Ergebnisse einer Untersuchung über die Resorption von Bufexamac nach rektaler Anwendung = Absorption du bufexamac après application rectale = Absorption of bufexamac after rectal applicationGLOWANIA, H.-J; HAMPL, B.H + G. Zeitschrift für Hautkrankheiten. 1988, Vol 63, Num 3, issn 0301-0481, 211Article

Determination of bufexamac in cream and ointment by high-performance liquid chromatographyKAMATA, K; AKIYAMA, K.Journal of chromatography. 1986, Vol 370, Num 2, pp 344-347, issn 0021-9673Article

ETUDE PRELIMINAIRE DU BUFEXAMAC EN DERMATOLOGIE PEDIATRIQUERICARD P; PERRAS M; PROULX C et al.1980; UNION MED. CAN.; ISSN 0041-6959; CAN; DA. 1980; VOL. 109; NO 8; PP. 1208-1211; ABS. ENG; BIBL. 13 REF.Article